Rare
lephants
Screener
Toggle theme
Monopar Therapeutics Inc.
MNPR
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
Shares Outstanding
Compare
←
5Y
10Y
MAX
→
Shares Outstanding
Chart
Table
Fiscal Year
Shares Outstanding
FY2016
0
FY2017
9.3M
FY2018
9.3M
FY2019
10.6M
FY2020
11.5M
Download CSV
